145 related articles for article (PubMed ID: 10468017)
1. Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier.
de Vrueh RL; Rump ET; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
Pharm Res; 1999 Aug; 16(8):1179-85. PubMed ID: 10468017
[TBL] [Abstract][Full Text] [Related]
2. Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.
de Vrueh RL; Rump ET; van De Bilt E; van Veghel R; Balzarini J; Biessen EA; van Berkel TJ; Bijsterbosch MK
Antimicrob Agents Chemother; 2000 Mar; 44(3):477-83. PubMed ID: 10681306
[TBL] [Abstract][Full Text] [Related]
3. Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus.
Bijsterbosch MK; Ying C; de Vrueh RL; de Clercq E; Biessen EA; Neyts J; van Berkel TJ
Mol Pharmacol; 2001 Sep; 60(3):521-7. PubMed ID: 11502883
[TBL] [Abstract][Full Text] [Related]
4. Novel hepatotrophic prodrugs of the antiviral nucleoside 9-(2-phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity.
Biessen EA; Valentijn AR; De Vrueh RL; Van De Bilt E; Sliedregt LA; Prince P; Bijsterbosch MK; Van Boom JH; Van Der Marel GA; Abrahams PJ; Van Berkel TJ
FASEB J; 2000 Sep; 14(12):1784-92. PubMed ID: 10973928
[TBL] [Abstract][Full Text] [Related]
5. Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles.
Bijsterbosch MK; van de Bilt H; van Berkel TJ
Biochem Pharmacol; 1996 Jul; 52(1):113-21. PubMed ID: 8678894
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
Naesens L; Balzarini J; Bischofberger N; De Clercq E
Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles.
Bijsterbosch MK; Schouten D; van Berkel TJ
Biochemistry; 1994 Nov; 33(47):14073-80. PubMed ID: 7947817
[TBL] [Abstract][Full Text] [Related]
8. Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys.
Lin CC; Yeh LT; Vitarella D; Hong Z; Erion MD
Antivir Chem Chemother; 2004 Nov; 15(6):307-17. PubMed ID: 15646644
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.
Starrett JE; Tortolani DR; Hitchcock MJ; Martin JC; Mansuri MM
Antiviral Res; 1992 Sep; 19(3):267-73. PubMed ID: 1332606
[TBL] [Abstract][Full Text] [Related]
10. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2).
Annaert P; Kinget R; Naesens L; de Clercq E; Augustijns P
Pharm Res; 1997 Apr; 14(4):492-6. PubMed ID: 9144737
[TBL] [Abstract][Full Text] [Related]
11. Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line.
Hatse S; De Clercq E; Balzarini J
Mol Pharmacol; 1998 Nov; 54(5):907-17. PubMed ID: 9804626
[TBL] [Abstract][Full Text] [Related]
12. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys.
Cundy KC; Fishback JA; Shaw JP; Lee ML; Soike KF; Visor GC; Lee WA
Pharm Res; 1994 Jun; 11(6):839-43. PubMed ID: 7937523
[TBL] [Abstract][Full Text] [Related]
13. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayers.
Annaert P; Gosselin G; Pompon A; Benzaria S; Valette G; Imbach JL; Naesens L; Hatse S; de Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Feb; 15(2):239-45. PubMed ID: 9523310
[TBL] [Abstract][Full Text] [Related]
16. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
Cerny J; Foster SA; Cheng YC
Mol Pharmacol; 1992 Sep; 42(3):537-44. PubMed ID: 1328849
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine in choriocarcinoma-bearing rats.
Hatse S; Naesens L; Degrève B; Segers C; Vandeputte M; Waer M; De Clercq E; Balzarini J
Int J Cancer; 1998 May; 76(4):595-600. PubMed ID: 9590139
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
Rossi L; Dominici S; Serafini S; Casabianca A; Cerasi A; Chiarantini L; Celeste AG; Cappellacci L; Franchetti P; Grifantini M; Magnani M
J Antimicrob Chemother; 2002 Sep; 50(3):365-74. PubMed ID: 12205061
[TBL] [Abstract][Full Text] [Related]
20. Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus.
Perno CF; Santoro N; Balestra E; Aquaro S; Cenci A; Lazzarino G; Di Pierro D; Tavazzi B; Balzarini J; Garaci E; Grimaldi S; Caliò R
Antiviral Res; 1997 Feb; 33(3):153-64. PubMed ID: 9037372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
